OBX

Obsidian Therapeutics, Inc.

Healthcare · Biotechnology

13.60$ +2.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement OBX
Line item	Q1 25	Q1 26
Revenue	–	0.00
Research & Development	–	0.26
Selling, General & Administrative	–	0.07
Total Operating Expenses	–	0.33
Operating Income	–	-0.33
Pre-Tax Income	–	-0.32
Net Income	–	-0.32
EBITDA	–	-0.32

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.